Company Filing History:
Years Active: 2006
Title: Ian Ashworth: Innovator in Asymmetric Synthesis
Introduction
Ian Ashworth is a notable inventor based in Stalybridge, GB. He has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. His innovative work has led to the development of a unique process that enhances the synthesis of substituted 1,4-dihydropyridines.
Latest Patents
Ian Ashworth holds 1 patent for his invention titled "Process for asymmetric synthesis of substituted 1,4-dihydropyridines." This patent describes a method for reacting a vinylogous amide with an α,β-unsaturated ketone in the presence of a silicon compound. The process results in the formation of a 1,5-diketone, which is subsequently converted into a 1,4-dihydropyridine. The synthesis of asymmetric substituted 1,4-dihydropyridines is achieved by preparing an asymmetric vinylogous amide through the reaction of a 1,3-cyclohexanedione with a substantially homo-chiral phenylethylamine.
Career Highlights
Ian Ashworth is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to apply his expertise in innovative chemical processes, contributing to advancements in pharmaceutical development.
Collaborations
Ian has collaborated with notable colleagues, including Ian Patel and Daniel Levin. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Ian Ashworth's contributions to asymmetric synthesis exemplify the impact of innovative thinking in chemistry. His patent and work at AstraZeneca highlight the importance of collaboration and creativity in advancing scientific knowledge.